A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
This accidental discovery, made by medical biochemist Henry Pownall, Ph.D., and his team at the Houston Methodist Research Institute, reveals a new pathway in the cholesterol-elimination chain that will be key to developing new drugs to lower cholesterol. Their findings are described in an article titled “ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate,” appearing online Oct. 26 and in print Nov. 21 in the American Heart Association’s Arteriosclerosis, Thrombosis, and Vascular Biology journal.
VIDEO: Dr. Pownall explains the research https://vimeo.com/239663429
Pownall, who is the corresponding author, said the initial purpose of their study was to prove the current model of cholesterol transport through the body was correct. It turns out, however, that the model was not quite right.
“The model people have been using for 40 years presumed that cholesterol was transported from the arteries with other lipids and proteins and entered a particle that stayed in the blood for several days before being cleared by the liver for disposal,” Pownall said. “What we discovered in the process was something different. We discovered the cholesterol skips all these steps and goes directly from this early particle to the liver in two minutes. This is a thousand times faster than what was formerly suspected.”
While most studies look at HDL cholesterol in its mature form found in blood, Pownall and his colleagues studied cholesterol in nascent HDL, an early form of HDL produced by cells. Cholesterol in the nascent HDL goes directly to the liver, largely skipping conversion to the mature form of HDL
Pownall stresses that it’s not that current practices of treating “bad” LDL cholesterol are incorrect, but instead that physicians and researchers need to better understand how the “good” HDL cholesterol contributes to cardiovascular disease and how to raise it in a way that protects the heart, because some patients with very high HDL numbers, which were always thought to be beneficial, are actually at risk.
“LDL cholesterol, the so-called ‘bad cholesterol’ is well controlled with the current statin therapies. The track record for these cholesterol-lowering drugs is indisputable, and they will continue to work,” Pownall said. “HDL, or the ‘good cholesterol,’ however, is a much trickier system. Not everything that raises it protects the heart and not everything that lowers it is bad for you. We will need to redesign new drugs to lower plasma cholesterol in a way that takes into account this new mechanism. We will look for interventions – maybe dietary, maybe pharmacological – that raise HDL cholesterol in a way that helps protect the arteries and prevent cardiovascular disease.”
Researchers collaborating with Pownall on this paper were Bingqing Xu, Baiba K. Gillard, Antonio M. Gotto Jr., and Corina Rosales, and the work was supported by a High-density Lipoprotein (HDL) Biogenesis and Speciation grant from the National Institutes of Health’s National Lung, Heart and Blood Institute (R01HL129767), Deutsche Forschungsgemeinschaft (Exc114-2) and Fondren Foundation.
For more information: ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate. Arteriosclerosis, Thrombosis, and Vascular Biology DOI: https://doi.org/10.1161/ATVBAHA.117.310290 (Oct. 26, 2017) B. Xu, B.K. Gillard, A.M. Gotto Jr., C. Rosales, H.J. Pownall.
@bigdock Great news! Sending you our best wishes.
If you love citrus, you will really love these recipes with options from salad to stir-fry.
Women with darker skin can get #skincancer, too. Our Dr. Susan Chon shares what you should know: https://t.co/02BBg4YNmw @thirdAGE #endcancer
Overcoming #cancer shapes 3 MD Anderson employees’ perspectives: https://t.co/cUt1DJj9F1 #endcancer https://t.co/FmZgRjUw0b
University of Houston@UHouston
Legacy is planting seeds in a garden you never get to see. Tonight we’re celebrating the legacy of @UHValentiSchool. Thank you @seguntheprogram for being MC and @jdbalart for the Impact Award https://t.co/tBmWEylyiU
Entering a new era: learn more about TMC3, the new translational research campus. https://t.co/pCLaez3zts
Be a part of the nation's largest autism research study. Get in-person help with signing up for SPARK for Autism at the Houston Museum of Natural Science during their sensory friendly event April 28. http://bit.ly/SPARKevents
An Army Veteran confronts his own trauma with a camera https://t.co/qoMYFKKZjq via @nytimes
In this interview with @ktrhnews, Dr. James Langabeer of @UTHealth_SBMI and @UTEmergencyMed discusses the decline in prescriptions for addictive painkillers: https://t.co/CMlYcJngA4
At 10 months old, David was so weak and behind in development that he couldn't even sit up. But now the bubbly 4-year-old is growing fast and swinging baseball bats. Read about his miraculous journey w/@UTPhysicians CARE Clinic. https://t.co/3chQLYaeex #ManyFacesOfUTHealth https://t.co/LZptSVgsDY
RT @UTCVSurgery: Another great free medical screening service brought to you by @UTPhysicians! Check out Dr Stuart Harlin on this morning’s…
Veterans serving Veterans: Researchers who served. This @usairforce Veteran volunteered as a pararescueman in Vietnam, and then went on to serve others with a career in orthopedic research. https://t.co/2NQHhSTmQx via @VeteransHealth on #VAntagePoint
At 10 months old, David was so weak and behind in development that he couldn't even sit up. But now the bubbly 4-year-old is growing fast and already swinging baseball bats. Read about his miraculous journey with the UT Physicians CARE Clinic. #ManyFacesOfUTHealth
Today’s #VeteranOfTheDay is Navy Veteran Willard Knockum Jr. Willard served from 1964 to 1971 during the Vietnam War. Willard joined the Navy in 1964. He was trained in counterinsurgency and survival surveillance reconnaissance and weapons at the Marine Base Camp in Pendleton, California. He became a Boatswain Mate, a role that fulfills a variety of tasks such as lookout duty, training and directing maintenance duties, damage control, operating and maintaining equipment and more. Willard also participated in North Atlantic Treaty Organization and anti-submarine warfare exercises. Willard served on the destroyer USS Fox 779 before he deployed to Vietnam in 1969 during the Vietnam War where he served in Saigon and Dong Tam. He was assigned to Military Assistance Command, a group of assault river boats that patrolled hostile waters around the Army Base at Dong Tam. For his service, Willard was awarded the Vietnam Service Medal and the Republic of Vietnam Campaign Medal. Willard now lives in Folsom, Louisiana as a retired United Postal Service mail handler. Thank you for your service, Willard!
Today’s #VeteranOfTheDay is @USNavy Veteran Willard Knockum, Jr https://t.co/7lDPTdSI86